Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2009
06/11/2009WO2009072705A1 Method for detecting nucleic acids by simultaneous isothermal amplification of nucleic acids and signal probe
06/11/2009WO2009072161A2 Device and method for microbiological analysis of biological samples
06/11/2009WO2009072147A1 Chimeric construct of mungbean yellow mosaic india virus (mymiv) and its uses thereof
06/11/2009WO2009072001A2 Slc9a3r1 directed diagnostics for neoplastic disease
06/11/2009WO2009071920A2 Methods for identifying epigenetically silenced genes and novel tumour suppressor genes
06/11/2009WO2009071904A1 Methods and compositions
06/11/2009WO2009071841A2 Egr1 modulators used in the treatment of alopecia
06/11/2009WO2009071831A1 Reaction medium for detecting and/or identifying staphyloccocus aureus
06/11/2009WO2009071721A1 Use of trefoil factor family 3 (tff3) in the prognosis of patients diagnosed with colorectal cancer
06/11/2009WO2009071720A1 Genomic imprinting for the prognosis of the course of colorectal adenocarcinoma
06/11/2009WO2009071665A1 Apparatus and method for detecting dna damage
06/11/2009WO2009071661A1 Methods for the treatment and diagnosis of bone mineral density related diseases
06/11/2009WO2009071659A1 Trophic factor for the treatment of retinal degenerative diseases
06/11/2009WO2009071649A1 Method for determining one of the two human immunodeficiency virus (hiv) integrase enzymatic activities
06/11/2009WO2009071404A1 Process for concentrating nucleic acid molecules
06/11/2009WO2009071301A2 Method for finding effectors of the protease activity of cis/trans-isomerases
06/11/2009WO2009071058A1 Method for diagnosing a genetic predisposition for vascular disease
06/11/2009WO2009070957A1 Inhibitor of the interaction between blys and ngr and use thereof
06/11/2009WO2009058007A3 Methods, reagents and kits for luciferase assay
06/11/2009WO2009055724A3 High throughput methods for functionally determining rna interference efficiency
06/11/2009WO2009055480A3 Tgf-beta gene expression signature in cancer prognosis
06/11/2009WO2009054996A3 Systems and methods for viral therapy
06/11/2009WO2009054957A3 Methods for diagnosis and treatment of chronic fatigue syndrome
06/11/2009WO2009043937A3 Method for detecting ralstonia solanacearum race 3 biovar 2
06/11/2009WO2009042457A4 Nucleic acid isolation in preserved whole blood
06/11/2009WO2009040461A3 Method for detection of the risk of developing proliferative vitreoretinopathy
06/11/2009WO2009039246A3 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
06/11/2009WO2009037492A3 Markers
06/11/2009WO2009033156A3 Methods and applications for target quantification
06/11/2009WO2009032185A3 Functional assay for indentification of loss-of-function mutations in genes
06/11/2009WO2009027978A8 NUCLEIC ACID SEQUENCES COMPRISING NF-ϰB BINDING SITE WITHIN O(6)-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER REGION AND USES THEREOF FOR THE TREATMENT OF CANCER AND IMMUNE-RELATED DISORDERS
06/11/2009WO2009025847A3 Methods for diagnosis, prognosis and methods of treatment
06/11/2009WO2009015799A3 Detection of platinum resistance
06/11/2009WO2008152404A3 Allelic determination
06/11/2009WO2008152305A3 Novel nitroreductase enzymatic substrates
06/11/2009WO2008076915A8 Treatment of pigs with pcv2 antigen
06/11/2009WO2007038155A3 Methods of diagnosing cardiovascular disease
06/11/2009WO2007021810A3 Microfluidic methods and apparatuses for fluid mixing and valving
06/11/2009WO2006137939A3 Compositions and methods for detecting group a streptococci
06/11/2009WO2006133361A3 Use of gene expression profiling to predict survival in cancer patient
06/11/2009WO2006078861A3 Method, system and apparatus for a time stamped visual motion sensor
06/11/2009WO2006078404A3 Notch1 variants associated with cardiovascular disease
06/11/2009WO2006029256A3 Compositions, methods, and systems for determining bovine parentage and identity
06/11/2009WO2006017171A3 Methods of diagnosing & treating obesity, diabetes and insulin resistance
06/11/2009WO2006010150A3 Housekeeping genes and methods for identifying the same
06/11/2009WO2005082041A3 Enhanced detection of rna using a panel of truncated gene-specific primers for reverse transcription
06/11/2009WO2003050137A3 Toll-like receptor 4 mutations
06/11/2009WO2003021227A3 Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
06/11/2009WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
06/11/2009WO2002061035A3 Mutant cells with enhanced resistance to desiccation
06/11/2009WO2002040632A3 Creation and identification of proteins having new dna binding specificities
06/11/2009WO2001061028A3 Methods and products for peptide based dna sequence identification and analysis
06/11/2009US20090151025 Indeterminate Gametophyte 1 (ig1), Mutations of ig1, Orthologs of ig1, and Uses Thereof
06/11/2009US20090151013 Modified ES cells and ES cell-specific genes
06/11/2009US20090150081 Automatic analyzer for enzyme immunoassays
06/11/2009US20090150080 Methods of genetic analysis involving the amplification of complementary duplicons
06/11/2009US20090149644 siRNA Targeting KRAS
06/11/2009US20090149640 Nucleic acid ladders
06/11/2009US20090149635 Antibodies to human zcytor17 ligand
06/11/2009US20090149530 Antiinfective Flavonol Compounds and Methods of Use Thereof
06/11/2009US20090149465 Aminotetralin compounds as mu opioid receptor antagonists
06/11/2009US20090149428 Methods for Assessing the Predisposition or Susceptibility to COPD
06/11/2009US20090149413 RORS as Modifiers of the p21 Pathway and Methods of Use
06/11/2009US20090149404 Oligonucleotide analogues and methods utilizing the same
06/11/2009US20090149377 METHODS FOR REGULATION OF p53 TRANSLATION AND FUNCTION
06/11/2009US20090149376 Pharmaceutical and Therapeutic Applications Relating to a Type 9 Adenylyl Cyclase Polymorphism in Asthma and Reversible Bronchial Obstruction
06/11/2009US20090149375 Use of the mst protein for the treatment of a thromboembolic disorder
06/11/2009US20090149374 Neuropeptides
06/11/2009US20090149349 Recombinant adenoviruses preparation and adenovirus banks
06/11/2009US20090149346 Strategies for gene expression analysis
06/11/2009US20090149342 Method for reduction of nonspecific binding in nucleic acid assays, nucleic acid synthesis and multiplex amplification reactions
06/11/2009US20090149341 Methods for detecting target analytes and enzymatic reactions
06/11/2009US20090149339 Methods of Identifying Modulators of Interaction Between PDZ Domain Proteins and PL Proteins
06/11/2009US20090149338 System for detecting protein-protein interactions
06/11/2009US20090149337 Use of an Extraction Control in a Method of Extracting Nucleic Acids
06/11/2009US20090149336 Indexed library of cells containing genomic modifications and methods of making and utilizing the same
06/11/2009US20090149333 Methods of Predicting Resistance or Sensitivity to Therapies for Cancer
06/11/2009US20090149332 Methods for determining the activity of adam-ts proteases using thiopeptolides
06/11/2009US20090149331 Methods and compositions for polypeptide engineering
06/11/2009US20090148955 Label-Free High-Throughput Optical Technique for Detecting Biomolecular Interactions
06/11/2009US20090148951 Thyroglobulin quantitation by mass spectrometry
06/11/2009US20090148948 Nucleic acids encoding a g-protein coupled receptor involved in taste transduction
06/11/2009US20090148940 Novel fluorescent proteins from aequorea coerulscens and methods for using same
06/11/2009US20090148939 Novel fluorescent proteins from aequorea coerulscens and methods for using same
06/11/2009US20090148915 Method for Producing L-Lysine or L-Threonine
06/11/2009US20090148911 Heat resistant polymerases for use as tools in genetic engineering; enzymatic extension of DNA strands; efficiently catalyzing the amplification by PCR (the polymerase chain reaction) of unusually long and faithful products
06/11/2009US20090148886 Methods of identifying compounds that decrease intraocular pressure
06/11/2009US20090148885 Fibroblast Growth Factor-Like Polypeptides
06/11/2009US20090148884 Lat1 transporters expressed in blood brain barrier cells
06/11/2009US20090148883 Biomarker for assessing response to fms treatment
06/11/2009US20090148882 Multiple coagulation test cartridge and method of using same
06/11/2009US20090148881 Geobacillus thermodenitrificans as well as the screening method and the uses thereof
06/11/2009US20090148880 Method and devices for treating individual biological cells
06/11/2009US20090148879 Stabilizing Compositions, Methods and Kits for Chemiluminescent Assays
06/11/2009US20090148878 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/11/2009US20090148877 Enzymatic methods for measuring plasma and tissue sphingomylelin and phosphatidylcholine
06/11/2009US20090148876 Methods for the generation of cartilage-like material by mechanical loading
06/11/2009US20090148875 Control markers for auto-detection of control solution and method of use
06/11/2009US20090148874 improved specificity for glucose as compared to maltose; improve the thermostability, the specific activity and the affinity for glucose of an s-GDH mutant having a substitution at position 348 by selecting mutations from the positions; specific detection or measurement of glucose in biological samples
06/11/2009US20090148873 Apparatus and method to measure platelet contractility